The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

Some 20 travel staff at the FDA, who made arrangements for the regulator’s inspectors, will be getting their jobs back, as ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

HHS Secretary Robert F. Kennedy Jr. wants to test all vaccines against a placebo but critics say it's not necessary as shots ...

Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsLavina Talukdar - Senior Vice President, ...